Our work could help to have a comprehensive understanding on the changes of CD4+ T cells and macrophages during an inflammatory process of T1DM, which could provide an experimental basis for the subsequent research of T1DM-related medication, especially about the CD4+ T cells and macrophages regulation. The gene discussed is CD4; the disease is type 1 diabetes mellitus.